ITM2B and Alzheimer disease: Treatment of AppNL-G-F mice with rh Bri2 BRICHOS R221E resulted in significant improvements in all AD-relevant features measured, whereas for AppNL-F mice no effects were seen on learning and memory, and reduced plaque burden and gliosis were only seen in the cortex (Figure 8).